When did JASPER THERAPEUTICS INC (JSPR) report earnings last quarter?
JASPER THERAPEUTICS INC (JSPR) last reported earnings on 3/30/2026.
NASDAQ:JSPR • US4718712023
Past quarterly earnings results for JASPER THERAPEUTICS INC (JSPR), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.32 | -0.76 | 57.85% | 80.25% | - | - | ||
| Q3 2025 | -1.25 | -1.24 | -0.88% | -0.81% | - | - | ||
| Q2 2025 | -1.74 | -1.35 | -28.61% | -79.38% | - | - | ||
| Q1 2025 | -1.41 | -1.34 | -5.32% | -36.89% | - | - | ||
| Q4 2024 | -1.62 | -1.25 | -29.09% | -8.00% | - | - | ||
| Q3 2024 | -1.24 | -1.09 | -13.47% | 22.50% | - | - | ||
| Q2 2024 | -0.97 | -1.11 | 12.67% | 35.33% | - | - | ||
| Q1 2024 | -1.03 | -1.25 | 17.57% | 35.63% | - | - | ||
| Q4 2023 | -1.50 | -1.65 | 8.94% | 58.33% | - | - | ||
| Q3 2023 | -1.60 | -1.58 | -1.04% | 50.00% | - | - | ||
| Q2 2023 | -1.50 | -1.53 | 1.83% | 48.28% | - | - | ||
| Q1 2023 | -1.60 | -1.66 | 3.41% | -166.67% | - | - | ||
| Q4 2022 | -3.60 | -3.67 | 1.96% | 54.43% | - | - | ||
| Q3 2022 | -3.20 | -3.49 | 8.40% | 84.24% | - | - | ||
| Q2 2022 | -2.90 | -3.20 | 9.26% | - | - | - | ||
| Q1 2022 | -0.60 | -3.57 | 83.19% | - | - | - | ||
| Q4 2021 | -7.90 | -3.50 | -125.48% | - | - | - | ||
| Q3 2021 | -20.30 | -2.82 | -620.43% | - | - | - | ||
| Q2 2021 | - | - | - | - | ||||
| Q1 2021 | - | - | - | - | ||||
| Q4 2020 | - | - | - | - | ||||
| Q3 2020 | - | - | - | - | ||||
| Q2 2020 | - | - | - | - |
Notes
JASPER THERAPEUTICS INC (JSPR) last reported earnings on 3/30/2026.
JASPER THERAPEUTICS INC (JSPR) beat EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, JASPER THERAPEUTICS INC (JSPR) has beaten EPS estimates in 1 out of 4 releases.